drugset / Trial / NCT07244757

Comparison of Two Dosing Regimens of Intravenous Ketorolac for Post-Cesarean Pain Control

NCT07244757

Completed 125 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

we aim to compare the analgesic efficacy of two intravenous ketorolac dosing regimens as part of a multimodal analgesic protocol that includes local wound infiltration for postoperative pain management after elective cesarean delivery.

Timeline

Start
2025-12-01
Primary completion
2026-04-28
Completion
2026-04-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 15 mg Intravenous
Comparator Ketorolac Other / unclassified 30 mg Intravenous

Indications

No indication recorded.